LOX and breast cancer: For that purpose, a LOX-driven spontaneous murine breast cancer model was established.[130] The tumour-bearing mice were daily dosed with inhibitor 9b at 70 mg/kg over 34 days, starting at the time when tumours became palpable, which was approximately 60 days after birth.